Toll-like receptors and B cells: functions and mechanisms
被引:77
|
作者:
Buchta, Claire M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USAUniv Iowa, Grad Program Immunol, Iowa City, IA 52242 USA
Buchta, Claire M.
[1
]
Bishop, Gail A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA
Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USAUniv Iowa, Grad Program Immunol, Iowa City, IA 52242 USA
Bishop, Gail A.
[1
,2
,3
,4
]
机构:
[1] Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[4] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA
Numerous reports have described Toll-like receptor (TLR) functions in myeloid cells such as dendritic cells (DCs) and macrophages, but relatively fewer studies have examined TLR responses in B lymphocytes. B cells express a wide variety of TLRs and are highly activated after TLR ligation, leading to enhancements in B cell survival, surface molecule expression, cytokine and antibody production, and antigen presentation. During an immune response, B cells can receive signals through TLRs as well as the B cell antigen receptor (BCR) and/or CD40. TLR ligation synergizes with signals through these receptors and augments both innate and adaptive immune functions of B lymphocytes. Additionally, targeting B cell TLRs may provide new therapies against certain types of cancer as well as autoimmune diseases. Here, we summarize TLR expression and contributions to both normal and pathogenic functions in mouse and human B cells.